BOIRON SA

BOIRON SA Share · FR0000061129 · 873532 (XPAR) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BOIRON SA
No Price
Closing Price XPAR 30.04.2026: 27,40 EUR
30.04.2026 15:39
Current Prices from BOIRON SA
ExchangeTickerCurrencyLast TradePriceDaily Change
XPAR: Paris
Paris
BOI.PA
EUR
30.04.2026 15:39
27,40 EUR
-
XHAN: Hannover
Hannover
BSAAPE29.HANB
EUR
30.04.2026 15:25
26,20 EUR
-
XLON: London
London
0DTF.L
EUR
30.04.2026 08:58
26,10 EUR
-
XDUS: Düsseldorf
Düsseldorf
BSAAPE29.DUSB
EUR
30.04.2026 06:11
25,70 EUR
-
XDQU: Quotrix
Quotrix
BSAAPE29.DUSD
EUR
30.04.2026 05:27
26,10 EUR
-
Share Float & Liquidity
Free Float 16,50 %
Shares Float 2,87 M
Shares Outstanding 17,36 M
Invested Funds

The following funds have invested in BOIRON SA:

Fund
iShares MSCI EMU Small Cap UCITS ETF EUR (Acc)
Vol. in million
271,39
Percentage (%)
0,03 %
Company Profile for BOIRON SA Share
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Company Data

Name BOIRON SA
Company Boiron S.A.
Website https://www.boiron.fr
Primary Exchange XPAR Paris
WKN 873532
ISIN FR0000061129
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Thierry Boiron
Market Capitalization 521 Mio
Country France
Currency EUR
Employees 2,5 T
Address 2, avenue de l’Ouest Lyonnais, 69510 Messimy
IPO Date 2008-07-29
Dividends from 'BOIRON SA'
Ex-Date Dividend per Share
03.06.2025 1,20 EUR
03.06.2025 1,37 USD
03.06.2024 1,35 EUR
03.06.2024 1,47 USD
18.10.2023 10,36 EUR
31.05.2023 1,10 EUR
31.05.2023 1,18 USD
01.06.2022 0,95 EUR
01.06.2022 1,02 USD
02.06.2021 0,95 EUR

Stock Splits

Date Split
14.07.2003 4:1
01.07.2003 4:1
04.07.1994 5:4

Ticker Symbols

Name Symbol
Over The Counter BOIRF
Düsseldorf BSAAPE29.DUSB
Frankfurt BON.F
Hannover BSAAPE29.HANB
London 0DTF.L
Paris BOI.PA
Quotrix BSAAPE29.DUSD
More Shares
Investors who hold BOIRON SA also have the following shares in their portfolio:
DK DB EUROG.GERMANY 5-10
DK DB EUROG.GERMANY 5-10 ETF
ISHRS MSCI JAPAN GBP HEDGED ETF (ACC)
ISHRS MSCI JAPAN GBP HEDGED ETF (ACC) ETF